Immuron Ltd Files 6-K with October Announcements
Ticker: IMRN · Form: 6-K · Filed: Oct 17, 2025 · CIK: 1660046
| Field | Detail |
|---|---|
| Company | Immuron LTD (IMRN) |
| Form Type | 6-K |
| Filed Date | Oct 17, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, announcement
TL;DR
Immuron dropped a 6-K on Oct 17th with two October announcements. Check it out.
AI Summary
Immuron Limited filed a Form 6-K on October 17, 2025, reporting two public announcements made during October 2025. The company, based in Carlton, Victoria, Australia, is a pharmaceutical preparations company.
Why It Matters
This filing provides an update on recent company activities and announcements, which could impact investor understanding of Immuron's current operations and strategic direction.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that reports previously made public announcements, not a filing with new material financial or operational information.
Key Players & Entities
- Immuron Limited (company) — Registrant
- October 2025 (date) — Reporting period for announcements
- October 17, 2025 (date) — Filing date
- Carlton, Victoria, Australia (location) — Company headquarters
FAQ
What type of report is Immuron Limited filing?
Immuron Limited is filing a Form 6-K, which is a Report of Foreign Private Issuer.
What is the filing date of this Form 6-K?
The Form 6-K was filed on October 17, 2025.
What period do the announcements covered by this 6-K relate to?
The announcements covered by this 6-K were made during the month of October 2025.
Where is Immuron Limited's principal executive office located?
Immuron Limited's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Does Immuron Limited file annual reports under Form 20-F or Form 40-F?
Immuron Limited indicates it files annual reports under Form 20-F.
Filing Stats: 313 words · 1 min read · ~1 pages · Grade level 18.4 · Accepted 2025-10-17 06:34:29
Filing Documents
- ea0261582-6k_immuron.htm (6-K) — 12KB
- ea026158201ex99-1_immuron.htm (EX-99.1) — 45KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001213900-25-099709.txt ( ) — 62KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of October 2025 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published two announcements (the “Public Notices”) to the Australian Securities Exchange on October 17, 2025 titled: - - Proposed issue of securities - IMC A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Proposed issue of securities - IMC 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: October 17, 2025 By: /s/ Phillip Hains Phillip Hains Company Secretary 3